SELLAS Life Sciences (SLS) Return on Sales [ROS] (2012 - 2022)
SELLAS Life Sciences (SLS) recorded Return on Sales [ROS] of -4195.00% in Q4 2022, down 3862.18 percentage points from -332.82% a year earlier but up 217.30 percentage points from the prior quarter.
Powered by 
Analysis
SELLAS Life Sciences (SLS) Return on Sales [ROS] (2012 - 2022) Analysis & Trends
Starting with Q3 2012, SELLAS Life Sciences' Return on Sales [ROS] history includes 23 quarters.
- Across earlier years, Return on Sales [ROS] came in at -332.82% in FY2021 (+560.97 pp) and -893.79% in FY2020.
- Quarterly Return on Sales [ROS] has ranged from -4412.30% in Q3 2022 to -39.39% in Q1 2021 over the past five years.
- On a year-over-year basis, Return on Sales [ROS] has declined for five consecutive quarters, with an average year-over-year change of -1655.00 percentage points over the last eight quarters.
- Peak year-over-year performance for Return on Sales [ROS] in the last five years was a gain of 445.06 percentage points in Q3 2021, against a drop of 4224.57 percentage points in Q3 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at -4412.30% (Q3 2022), -4395.40% (Q2 2022) and -1673.50% (Q1 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | SELLAS Life Sciences | 2.37 Bn | 2.37 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | -4,195.00% |
| Sep 30, 2022 | -4,412.30% |
| Jun 30, 2022 | -4,395.40% |
| Mar 31, 2022 | -1,673.50% |
| Dec 31, 2021 | -332.82% |
| Sep 30, 2021 | -187.73% |
| Jun 30, 2021 | -234.37% |
| Mar 31, 2021 | -39.39% |
| Dec 31, 2020 | -218.89% |
| Sep 30, 2020 | -632.79% |
| Jun 30, 2020 | -348.52% |
| Mar 31, 2020 | -236.04% |
| Jun 30, 2015 | -268.57% |
| Mar 31, 2015 | -324.07% |
| Dec 31, 2014 | -303.38% |
| Sep 30, 2014 | -652.28% |
| Jun 30, 2014 | -677.09% |
| Mar 31, 2014 | -545.28% |
| Dec 31, 2013 | -219.06% |
| Sep 30, 2013 | -425.49% |
API Access
SELLAS Life Sciences Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=SLS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "SLS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=SLS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();